Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
No-Receipt date
2018-01917 - 06/06/2018
No-Filing date
20180800020 - 06/06/2018
No-Granting date
8000741 - 03/02/2020
No-EPO application date
-
No-EPO granting date
-
Gazette No-Publication date of application
10/2018 - 25/01/2019
Gazette No-Publication date of granted patent
2/2020 - 15/04/2020
Expiration date
18/11/2032
Kind of title
Supplementary Protection Certificate for Medicinal Products
Legal status
VALID
Priorities
GB092107501/12/2009/GB
Active Substance of Supplementary Certificates
ΠΡΟΪΟΝ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΣΥΝΔΥΑΣΜΟΥ ΠΕΡΙΛΑΜΒΑΝΟΝ ΕΝΑ ΦΑΡΜΑΚΕΥΤΙΚΩΣ ΑΠΟΔΕΚΤΟ ΑΛΑΣ UMECLIDINIUM (π.χ. UMECLIDINIUM BROMIDE),VILANTEROL ¨Η ΕΝΑ ΦΑΡΜΑΚΕΥΤΙΚΩΣ ΑΠΟΔΕΚΤΟ ΑΛΑΣ ΑΥΤΟΥ (π.χ. VILANTEROL TRIFENATATE) KAI FLUTICASONE FUROATE
IPC Classification
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20180400334
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
854883
GLAXO GROUP LIMITED
980 GREAT WEST ROAD
BRENTFORD, MIDDLESEX TW8 9GS
UNITED KINGDOM (GREAT BRITAIN)
Inventors
Code
Firstname
Surname
2120809
BAKER, DARRELL
2120810
BRUCE, MARK
2120811
CRATER, GLENN
2120812
NOGA, BRIAN
2120813
THOMAS, MARIAN
2120814
WIRE, PATRICK
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).